Pharmacokinetic and Safety Studies of HRS-7535 in Subjects With Moderate Renal Insufficiency and Healthy Subjects

Phase 1 Completed 16 enrolled Shandong Suncadia Medicine Co., Ltd.

Non-randomizedParallel-groupOpen-labelTreatment

Summary

The study is being conducted to evaluate and compare the pharmacokinetics of HRS-7535 tablets in subjects with moderate renal insufficiency and healthy subjects.

Timeline

Start: 2023-12-21
Primary completion: 2024-03-13
Completion: 2024-03-13

Drugs

Evaluation	Drug	Modality	Dose	Route
Subject	HRS-7535	Small molecule	—	—

Pharmacokinetic and Safety Studies of HRS-7535 in Subjects With Moderate Renal Insufficiency and Healthy Subjects

Summary

Timeline

Drugs

Indications